SYHLF yields 0.85% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, SYHLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYHLF + JNJ for your $10,000?
Symphony Holdings Limited, an investment holding company, primarily operates as a retailing company. It operates through Branding, Retailing, and Financial Services segments. The company is involved in the retailing and provision of sourcing services for branded apparel, swimwear, and accessories; manufacturing and trading of healthcare products; and development and management of PONY and SKINS trademarks. It also manages and operates outlet malls, duty free shops, and fashion stores; and provides securities brokerage, margin financing, underwriting and placing, financial consulting, and money lending services. In addition, the company offers information, technology, corporate, and portfolio management services; accountancy, legal, secretarial, and cruiser services; and online trading platform support services. Further, it engages in the trading, retailing, and distribution of swimming apparel and accessories; property investment and holding activities; holding of club debentures; sub-licensing of trademark rights; and trading and wholesaling of sportswear. It operates in the People's Republic of China, Hong Kong, other Asian countries, the United States, the United Kingdom, and internationally. The company was formerly known as Liang Shing (Holdings) Limited and changed its name to Symphony Holdings Limited in 1997. Symphony Holdings Limited was incorporated in 1993 and is based in North Point, Hong Kong.
Full SYHLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.